These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease. Schumacher A; Seljeflot I; Lerkerød AB; Sommervoll L; Otterstad JE; Arnesen H Eur J Clin Invest; 2005 Jul; 35(7):431-7. PubMed ID: 16008544 [TBL] [Abstract][Full Text] [Related]
23. [Chlamydia pneumoniae and cerebrovascular disease]. Linares-Palomino J; Gutiérrez J; López-Espada C; Ros E; Moreno J; Pérez T; Rodríguez M; Maroto MC Rev Neurol; 2001 Feb 1-15; 32(3):201-6. PubMed ID: 11310268 [TBL] [Abstract][Full Text] [Related]
24. Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Gerdes VE; Verkooyen RP; Kwa VI; de Groot E; van Gorp EC; ten Cate H; Brandjes DP; Büller HR Atherosclerosis; 2003 Mar; 167(1):65-71. PubMed ID: 12618269 [TBL] [Abstract][Full Text] [Related]
25. [Role of chronic infection and heat shock proteins in peripheral arterial disease]. Rabczyński M; Adamiec R Przegl Lek; 2007; 64(6):419-22. PubMed ID: 18159851 [TBL] [Abstract][Full Text] [Related]
26. The prevalence of Chlamydia pneumoniae antibodies in Thai patients with coronary artery disease. Leowattana W; Mahanonda N; Bhuripunyo K; Leelarasamee A; Pokum S; Suwimol B J Med Assoc Thai; 1999 Aug; 82(8):792-7. PubMed ID: 10511787 [TBL] [Abstract][Full Text] [Related]
27. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. Berger M; Schröder B; Daeschlein G; Schneider W; Busjahn A; Buchwalow I; Luft FC; Haller H J Lab Clin Med; 2000 Sep; 136(3):194-200. PubMed ID: 10985497 [TBL] [Abstract][Full Text] [Related]
29. [Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries]. Imai S; Matsubara T; Hori T; Nakagawa I; Ozaki K; Hatada K; Mezaki T; Nasuno A; Kubota K; Tanaka T; Aizawa Y J Cardiol; 2001 Jun; 37(6):293-9. PubMed ID: 11433804 [TBL] [Abstract][Full Text] [Related]
30. Association of Chlamydophila pneumoniae DNA in peripheral blood mononuclear cells and IgA antibody with atherosclerotic diseases. Sawayama Y; Kikuchi K; Tatsukawa M; Hayashi S; Taira Y; Furusyo N; Hayashi J Fukuoka Igaku Zasshi; 2009 Sep; 100(9):305-12. PubMed ID: 20077843 [TBL] [Abstract][Full Text] [Related]
31. Chlamydia pneumoniae infection and nonspecific aortoarteritis: search for a link with a nonatherosclerotic inflammatory arterial disease. Bahl VK; Sengupta PP; Sathpathy G; Sharma A; Narang R; Sharma S; Manchanda SC Indian Heart J; 2002; 54(1):46-9. PubMed ID: 11999087 [TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of Chlamydophila pneumoniae in ischaemic heart disease. Monno R; Fumarola L; Trerotoli P; Giannelli G; Correale M; Brunetti D; Di Biase M New Microbiol; 2010 Oct; 33(4):381-5. PubMed ID: 21213597 [TBL] [Abstract][Full Text] [Related]
33. [Presence of Chlamydia pneumoniae antibodies in patients with ischemic heart disease and acute myocardial infarct]. Reiner Z; Burek V; Goldner V; Jug M; Zrnić T; Oresković K; Culig J Lijec Vjesn; 2000; 122(11-12):263-9. PubMed ID: 11291268 [TBL] [Abstract][Full Text] [Related]
34. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis]. Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994 [TBL] [Abstract][Full Text] [Related]
35. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris. Altannavch Ts; Roubalová K; Broz J; Hrubá D; Andĕl M Cent Eur J Public Health; 2003 Jun; 11(2):102-6. PubMed ID: 12884557 [TBL] [Abstract][Full Text] [Related]
37. Anti chlamydia antibodies in patients with thoracic and abdominal aortic aneurysms. Schillinger M; Domanovits H; Mlekusch W; Bayegan K; Khanakah G; Laggner AN; Minar E; Stanek G Wien Klin Wochenschr; 2002 Dec; 114(23-24):972-7. PubMed ID: 12635464 [TBL] [Abstract][Full Text] [Related]
38. [The presence of anti-Chlamydia pneumoniae antibodies in peripheral vascular and neurological disorders]. Gutiérrez-Fernández J; Linares-Palomino J; Fernández-Sánchez F; Guerrero-Fernández M; López Espada C; Ros-Díez E; Rodríguez Fernández M; Maroto-Vela MC Rev Neurol; 2001 Mar 16-31; 32(6):501-5. PubMed ID: 11353985 [TBL] [Abstract][Full Text] [Related]
39. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test. Jauhiainen T; Tuomi T; Leinonen M; Kark JD; Saikku P J Clin Microbiol; 1994 Mar; 32(3):839-40. PubMed ID: 8195403 [TBL] [Abstract][Full Text] [Related]
40. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure. Song H; Tasaki H; Yashiro A; Okazaki M; Ioka T; Taniguchi H; Nakashima Y Clin Nephrol; 2001 Nov; 56(5):346-52. PubMed ID: 11758004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]